Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 16.707
Filtrer
1.
PLoS One ; 19(8): e0308236, 2024.
Article de Anglais | MEDLINE | ID: mdl-39106259

RÉSUMÉ

A fundamental computer vision task called semantic segmentation has significant uses in the understanding of medical pictures, including the segmentation of tumors in the brain. The G-Shaped Net architecture appears in this context as an innovative and promising design that combines components from many models to attain improved accuracy and efficiency. In order to improve efficiency, the G-Shaped Net architecture synergistically incorporates four fundamental components: the Self-Attention, Squeeze Excitation, Fusion, and Spatial Pyramid Pooling block structures. These factors work together to improve the precision and effectiveness of brain tumor segmentation. Self-Attention, a crucial component of G-Shaped architecture, gives the model the ability to concentrate on the image's most informative areas, enabling accurate localization of tumor boundaries. By adjusting channel-wise feature maps, Squeeze Excitation completes this by improving the model's capacity to capture fine-grained information in the medical pictures. Since the G-Shaped model's Spatial Pyramid Pooling component provides multi-scale contextual information, the model is capable of handling tumors of various sizes and complexity levels. Additionally, the Fusion block architectures combine characteristics from many sources, enabling a thorough comprehension of the image and improving the segmentation outcomes. The G-Shaped Net architecture is an asset for medical imaging and diagnostics and represents a substantial development in semantic segmentation, which is needed more and more for accurate brain tumor segmentation.


Sujet(s)
Tumeurs du cerveau , Sémantique , Humains , Tumeurs du cerveau/imagerie diagnostique , Tumeurs du cerveau/anatomopathologie , Traitement d'image par ordinateur/méthodes , Algorithmes , Imagerie par résonance magnétique/méthodes ,
2.
Hum Brain Mapp ; 45(11): e26801, 2024 Aug 01.
Article de Anglais | MEDLINE | ID: mdl-39087903

RÉSUMÉ

Damage to the posterior language area (PLA), or Wernicke's area causes cortical reorganization in the corresponding regions of the contralateral hemisphere. However, the details of reorganization within the ipsilateral hemisphere are not fully understood. In this context, direct electrical stimulation during awake surgery can provide valuable opportunities to investigate neuromodulation of the human brain in vivo, which is difficult through the non-invasive approaches. Thus, in this study, we aimed to investigate the characteristics of the cortical reorganization of the PLA within the ipsilateral hemisphere. Sixty-two patients with left hemispheric gliomas were divided into groups depending on whether the lesion extended to the PLA. All patients underwent direct cortical stimulation with a picture-naming task. We further performed functional connectivity analyses using resting-state functional magnetic resonance imaging (MRI) in a subset of patients and calculated betweenness centrality, an index of the network importance of brain areas. During direct cortical stimulation, the regions showing positive (impaired) responses in the non-PLA group were localized mainly in the posterior superior temporal gyrus (pSTG), whereas those in the PLA group were widely distributed from the pSTG to the posterior supramarginal gyrus (pSMG). Notably, the percentage of positive responses in the pSMG was significantly higher in the PLA group (47%) than in the non-PLA group (8%). In network analyses of functional connectivity, the pSMG was identified as a hub region with high betweenness centrality in both the groups. These findings suggest that the language area can spread beyond the PLA to the pSMG, a hub region, in patients with lesion progression to the pSTG. The change in the pattern of the language area may be a compensatory mechanism to maintain efficient brain networks.


Sujet(s)
Tumeurs du cerveau , Imagerie par résonance magnétique , Réseau nerveux , Centre de Wernicke , Humains , Tumeurs du cerveau/imagerie diagnostique , Tumeurs du cerveau/physiopathologie , Mâle , Femelle , Adulte d'âge moyen , Adulte , Centre de Wernicke/imagerie diagnostique , Centre de Wernicke/physiopathologie , Centre de Wernicke/physiologie , Réseau nerveux/imagerie diagnostique , Réseau nerveux/physiopathologie , Gliome/imagerie diagnostique , Gliome/physiopathologie , Gliome/chirurgie , Gliome/anatomopathologie , Stimulation électrique , Sujet âgé , Langage , Connectome , Lobe pariétal/imagerie diagnostique , Lobe pariétal/physiopathologie , Cartographie cérébrale , Jeune adulte
3.
PLoS One ; 19(8): e0306492, 2024.
Article de Anglais | MEDLINE | ID: mdl-39088437

RÉSUMÉ

Brain tumor detection in clinical applications is a complex and challenging task due to the intricate structures of the human brain. Magnetic Resonance (MR) imaging is widely preferred for this purpose because of its ability to provide detailed images of soft brain tissues, including brain tissue, cerebrospinal fluid, and blood vessels. However, accurately detecting brain tumors from MR images remains an open problem for researchers due to the variations in tumor characteristics such as intensity, texture, size, shape, and location. To address these issues, we propose a method that combines multi-level thresholding and Convolutional Neural Networks (CNN). Initially, we enhance the contrast of brain MR images using intensity transformations, which highlight the infected regions in the images. Then, we use the suggested CNN architecture to classify the enhanced MR images into normal and abnormal categories. Finally, we employ multi-level thresholding based on Tsallis entropy (TE) and differential evolution (DE) to detect tumor region(s) from the abnormal images. To refine the results, we apply morphological operations to minimize distortions caused by thresholding. The proposed method is evaluated using the widely used Harvard Medical School (HMS) dataset, and the results demonstrate promising performance with 99.5% classification accuracy and 92.84% dice similarity coefficient. Our approach outperforms existing state-of-the-art methods in brain tumor detection and automated disease diagnosis from MR images.


Sujet(s)
Tumeurs du cerveau , Encéphale , Imagerie par résonance magnétique , , Humains , Imagerie par résonance magnétique/méthodes , Tumeurs du cerveau/imagerie diagnostique , Encéphale/imagerie diagnostique , Traitement d'image par ordinateur/méthodes , Algorithmes
4.
BMC Cancer ; 24(1): 953, 2024 Aug 05.
Article de Anglais | MEDLINE | ID: mdl-39103758

RÉSUMÉ

BACKGROUND AND PURPOSE: In the context of the widespread availability of magnetic resonance imaging (MRI) and aggressive salvage irradiation techniques, there has been controversy surrounding the use of prophylactic cranial irradiation (PCI) for small-cell lung cancer (SCLC) patients. This study aimed to explore whether regular brain MRI plus salvage brain irradiation (SBI) is not inferior to PCI in patients with limited-stage SCLC (LS-SCLC). METHODS: This real-world multicenter study, which was conducted between January 2014 and September 2020 at three general hospitals, involved patients with LS-SCLC who had a good response to initial chemoradiotherapy and no brain metastasis confirmed by MRI. Overall survival (OS) was compared between patients who did not receive PCI for various reasons but chose regular MRI surveillance and followed salvage brain irradiation (SBI) when brain metastasis was detected and patients who received PCI. RESULTS: 120 patients met the inclusion criteria. 55 patients received regular brain MRI plus SBI (SBI group) and 65 patients received PCI (PCI group). There was no statistically significant difference in median OS between the two groups (27.14 versus 33.00 months; P = 0.18). In the SBI group, 32 patients underwent whole brain radiotherapy and 23 patients underwent whole brain radiotherapy + simultaneous integrated boost. On multivariate analysis, only extracranial metastasis was independently associated with poor OS in the SBI group. CONCLUSION: The results of this real-world study showed that MRI surveillance plus SBI is not inferior to PCI in OS for LS-SCLC patients who had a good response to initial chemoradiotherapy.


Sujet(s)
Tumeurs du cerveau , Irradiation crânienne , Tumeurs du poumon , Imagerie par résonance magnétique , Thérapie de rattrapage , Carcinome pulmonaire à petites cellules , Humains , Carcinome pulmonaire à petites cellules/radiothérapie , Carcinome pulmonaire à petites cellules/imagerie diagnostique , Carcinome pulmonaire à petites cellules/mortalité , Carcinome pulmonaire à petites cellules/anatomopathologie , Mâle , Femelle , Imagerie par résonance magnétique/méthodes , Tumeurs du poumon/radiothérapie , Tumeurs du poumon/mortalité , Tumeurs du poumon/imagerie diagnostique , Tumeurs du poumon/anatomopathologie , Adulte d'âge moyen , Sujet âgé , Irradiation crânienne/méthodes , Tumeurs du cerveau/secondaire , Tumeurs du cerveau/radiothérapie , Tumeurs du cerveau/imagerie diagnostique , Tumeurs du cerveau/mortalité , Études rétrospectives , Stadification tumorale , Adulte , Chimioradiothérapie/méthodes
5.
Acta Neurochir (Wien) ; 166(1): 317, 2024 Aug 01.
Article de Anglais | MEDLINE | ID: mdl-39090435

RÉSUMÉ

Objective - Addressing the challenges that come with identifying and delineating brain tumours in intraoperative ultrasound. Our goal is to both qualitatively and quantitatively assess the interobserver variation, amongst experienced neuro-oncological intraoperative ultrasound users (neurosurgeons and neuroradiologists), in detecting and segmenting brain tumours on ultrasound. We then propose that, due to the inherent challenges of this task, annotation by localisation of the entire tumour mass with a bounding box could serve as an ancillary solution to segmentation for clinical training, encompassing margin uncertainty and the curation of large datasets. Methods - 30 ultrasound images of brain lesions in 30 patients were annotated by 4 annotators - 1 neuroradiologist and 3 neurosurgeons. The annotation variation of the 3 neurosurgeons was first measured, and then the annotations of each neurosurgeon were individually compared to the neuroradiologist's, which served as a reference standard as their segmentations were further refined by cross-reference to the preoperative magnetic resonance imaging (MRI). The following statistical metrics were used: Intersection Over Union (IoU), Sørensen-Dice Similarity Coefficient (DSC) and Hausdorff Distance (HD). These annotations were then converted into bounding boxes for the same evaluation. Results - There was a moderate level of interobserver variance between the neurosurgeons [ I o U : 0.789 , D S C : 0.876 , H D : 103.227 ] and a larger level of variance when compared against the MRI-informed reference standard annotations by the neuroradiologist, mean across annotators [ I o U : 0.723 , D S C : 0.813 , H D : 115.675 ] . After converting the segments to bounding boxes, all metrics improve, most significantly, the interquartile range drops by [ I o U : 37 % , D S C : 41 % , H D : 54 % ] . Conclusion - This study highlights the current challenges with detecting and defining tumour boundaries in neuro-oncological intraoperative brain ultrasound. We then show that bounding box annotation could serve as a useful complementary approach for both clinical and technical reasons.


Sujet(s)
Tumeurs du cerveau , Humains , Tumeurs du cerveau/chirurgie , Tumeurs du cerveau/imagerie diagnostique , Tumeurs du cerveau/anatomopathologie , Échographie/méthodes , Neurochirurgiens , Biais de l'observateur , Imagerie par résonance magnétique/méthodes , Procédures de neurochirurgie/méthodes
6.
Mol Imaging ; 23: 15353508241261583, 2024.
Article de Anglais | MEDLINE | ID: mdl-38952400

RÉSUMÉ

Objective: To investigate the performance of diffusion-tensor imaging (DTI) and hydrogen proton magnetic resonance spectroscopy (1H-MRS) parameters in predicting the immunohistochemistry (IHC) biomarkers of glioma. Methods: Patients with glioma confirmed by pathology from March 2015 to September 2019 were analyzed, the preoperative DTI and 1H-MRS images were collected, apparent diffusion coefficient (ADC) and fractional anisotropy (FA), in the lesion area were measured, the relative values relative ADC (rADC) and relative FA (rFA) were obtained by the ratio of them in the lesion area to the contralateral normal area. The peak of each metabolite in the lesion area of 1H-MRS image: N-acetylaspartate (NAA), choline (Cho), and creatine (Cr), and metabolite ratio: NAA/Cho, NAA/(Cho + Cr) were selected and calculated. The preoperative IHC data were collected including CD34, Ki-67, p53, S-100, syn, vimentin, NeuN, Nestin, and glial fibrillary acidic protein. Results: One predicting parameter of DTI was screened, the rADC of the Ki-67 positive group was lower than that of the negative group. Two parameters of 1H-MRS were found to have significant reference values for glioma grades, the NAA and Cr decreased as the grade of glioma increased, moreover, Ki-67 Li was negatively correlated with NAA and Cr. Conclusion: NAA and Cr have potential application value in predicting glioma grades and tumor proliferation activity. Only rADC has predictive value for Ki-67 expression among DTI parameters.


Sujet(s)
Tumeurs du cerveau , Gliome , Immunohistochimie , Humains , Gliome/imagerie diagnostique , Gliome/anatomopathologie , Gliome/métabolisme , Mâle , Femelle , Adulte d'âge moyen , Adulte , Tumeurs du cerveau/imagerie diagnostique , Tumeurs du cerveau/anatomopathologie , Tumeurs du cerveau/métabolisme , Imagerie par tenseur de diffusion/méthodes , Imagerie par résonance magnétique/méthodes , Sujet âgé , Spectroscopie par résonance magnétique du proton/méthodes , Jeune adulte
7.
Neurosurg Rev ; 47(1): 301, 2024 Jul 02.
Article de Anglais | MEDLINE | ID: mdl-38954077

RÉSUMÉ

Given that glioma cells tend to infiltrate and migrate along WM tracts, leading to demyelination and axonal injuries, Diffusion Tensor Imaging (DTI) emerged as a promising tool for identifying major "high-risk areas" of recurrence within the peritumoral brain zone (PBZ) or at a distance throughout the adjacents white matter tracts. Of our systematic review is to answer the following research question: In patients with brain tumor, is DTI able to recognizes within the peri-tumoral brain zone (PBZ) areas more prone to local (near the surgical cavity) or remote recurrence compared to the conventional imaging techniques?. We conducted a comprehensive literature search to identify relevant studies in line with the PRISMA-P (Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols) guidelines. 15 papers were deemed compatible with our research question and included. To enhance the paper's readability, we have categorized our findings into two distinct groups: the first delves into the role of DTI in detecting PBZ sub-regions of infiltration and local recurrences (n = 8), while the second group explores the feasibility of DTI in detecting white matter tract infiltration and remote recurrences (n = 7). DTI values and, within a broader framework, radiomics investigations can provide precise, voxel-by-voxel insights into the state of PBZ and recurrences. Better defining the regions at risk for potential recurrence within the PBZ and along WM bundles will allow targeted therapy.


Sujet(s)
Tumeurs du cerveau , Imagerie par tenseur de diffusion , Gliome , Récidive tumorale locale , Humains , Imagerie par tenseur de diffusion/méthodes , Gliome/imagerie diagnostique , Gliome/anatomopathologie , Tumeurs du cerveau/imagerie diagnostique , Tumeurs du cerveau/anatomopathologie , Récidive tumorale locale/imagerie diagnostique , Substance blanche/imagerie diagnostique , Substance blanche/anatomopathologie
8.
Sci Rep ; 14(1): 15057, 2024 07 01.
Article de Anglais | MEDLINE | ID: mdl-38956224

RÉSUMÉ

Image segmentation is a critical and challenging endeavor in the field of medicine. A magnetic resonance imaging (MRI) scan is a helpful method for locating any abnormal brain tissue these days. It is a difficult undertaking for radiologists to diagnose and classify the tumor from several pictures. This work develops an intelligent method for accurately identifying brain tumors. This research investigates the identification of brain tumor types from MRI data using convolutional neural networks and optimization strategies. Two novel approaches are presented: the first is a novel segmentation technique based on firefly optimization (FFO) that assesses segmentation quality based on many parameters, and the other is a combination of two types of convolutional neural networks to categorize tumor traits and identify the kind of tumor. These upgrades are intended to raise the general efficacy of the MRI scan technique and increase identification accuracy. Using MRI scans from BBRATS2018, the testing is carried out, and the suggested approach has shown improved performance with an average accuracy of 98.6%.


Sujet(s)
Tumeurs du cerveau , Imagerie par résonance magnétique , , Imagerie par résonance magnétique/méthodes , Tumeurs du cerveau/imagerie diagnostique , Tumeurs du cerveau/anatomopathologie , Tumeurs du cerveau/classification , Humains , Traitement d'image par ordinateur/méthodes , Algorithmes , Encéphale/imagerie diagnostique , Encéphale/anatomopathologie
9.
BMC Surg ; 24(1): 216, 2024 Jul 27.
Article de Anglais | MEDLINE | ID: mdl-39068399

RÉSUMÉ

BACKGROUND: In assessing the clinical utility and safety of 3.0 T intraoperative magnetic resonance imaging (iMRI) combined with multimodality functional MRI (fMRI) guidance in the resection of functional area gliomas, we conducted a study. METHOD: Among 120 patients with newly diagnosed functional area gliomas who underwent surgical treatment, 60 were included in each group: the integrated group with iMRI and fMRI and the conventional navigation group. Between-group comparisons were made for the extent of resection (EOR), preoperative and postoperative activities of daily living based on the Karnofsky performance status, surgery duration, and postoperative intracranial infection rate. RESULTS: Compared to the conventional navigation group, the integrated navigation group with iMRI and fMRI exhibited significant improvements in tumor resection (complete resection rate: 85.0% vs. 60.0%, P = 0.006) and postoperative life self-care ability scores (Karnofsky score) (median ± interquartile range: 90 ± 25 vs. 80 ± 30, P = 0.013). Additionally, although the integrated navigation group with iMRI and fMRI required significantly longer surgeries than the conventional navigation group (mean ± standard deviation: 411.42 ± 126.4 min vs. 295.97 ± 96.48 min, P<0.0001), there was no significant between-group difference in the overall incidence of postoperative intracranial infection (16.7% vs. 18.3%, P = 0.624). CONCLUSION: The combination of 3.0 T iMRI with multimodal fMRI guidance enables effective tumor resection with minimal neurological damage.


Sujet(s)
Tumeurs du cerveau , Gliome , Imagerie par résonance magnétique , Humains , Mâle , Femelle , Tumeurs du cerveau/chirurgie , Tumeurs du cerveau/imagerie diagnostique , Gliome/chirurgie , Gliome/imagerie diagnostique , Adulte d'âge moyen , Imagerie par résonance magnétique/méthodes , Adulte , Sujet âgé , Études rétrospectives , Chirurgie assistée par ordinateur/méthodes , Neuronavigation/méthodes , Résultat thérapeutique , Surveillance peropératoire/méthodes , Procédures de neurochirurgie/méthodes
10.
Sci Rep ; 14(1): 15660, 2024 07 08.
Article de Anglais | MEDLINE | ID: mdl-38977779

RÉSUMÉ

Brain tumors, often referred to as intracranial tumors, are abnormal tissue masses that arise from rapidly multiplying cells. During medical imaging, it is essential to separate brain tumors from healthy tissue. The goal of this paper is to improve the accuracy of separating tumorous regions from healthy tissues in medical imaging, specifically for brain tumors in MRI images which is difficult in the field of medical image analysis. In our research work, we propose IC-Net (Inverted-C), a novel semantic segmentation architecture that combines elements from various models to provide effective and precise results. The architecture includes Multi-Attention (MA) blocks, Feature Concatenation Networks (FCN), Attention-blocks which performs crucial tasks in improving brain tumor segmentation. MA-block aggregates multi-attention features to adapt to different tumor sizes and shapes. Attention-block is focusing on key regions, resulting in more effective segmentation in complex images. FCN-block captures diverse features, making the model more robust to various characteristics of brain tumor images. Our proposed architecture is used to accelerate the training process and also to address the challenges posed by the diverse nature of brain tumor images, ultimately leads to potentially improved segmentation performance. IC-Net significantly outperforms the typical U-Net architecture and other contemporary effective segmentation techniques. On the BraTS 2020 dataset, our IC-Net design obtained notable outcomes in Accuracy, Loss, Specificity, Sensitivity as 99.65, 0.0159, 99.44, 99.86 and DSC (core, whole, and enhancing tumors as 0.998717, 0.888930, 0.866183) respectively.


Sujet(s)
Algorithmes , Tumeurs du cerveau , Imagerie par résonance magnétique , Humains , Tumeurs du cerveau/imagerie diagnostique , Tumeurs du cerveau/anatomopathologie , Imagerie par résonance magnétique/méthodes , Traitement d'image par ordinateur/méthodes , Interprétation d'images assistée par ordinateur/méthodes ,
11.
PLoS One ; 19(7): e0307818, 2024.
Article de Anglais | MEDLINE | ID: mdl-39058662

RÉSUMÉ

INTRODUCTION: High grade astrocytic glioma (HGG) is a lethal solid malignancy with high recurrence rates and limited survival. While several cytotoxic agents have demonstrated efficacy against HGG, drug sensitivity testing platforms to aid in therapy selection are lacking. Patient-derived organoids (PDOs) have been shown to faithfully preserve the biological characteristics of several cancer types including HGG, and coupled with the experimental-analytical hybrid platform Quadratic Phenotypic Optimization Platform (QPOP) which evaluates therapeutic sensitivity at a patient-specific level, may aid as a tool for personalized medical decisions to improve treatment outcomes for HGG patients. METHODS: This is an interventional, non-randomized, open-label study, which aims to enroll 10 patients who will receive QPOP-guided chemotherapy at the time of first HGG recurrence following progression on standard first-line therapy. At the initial presentation of HGG, tumor will be harvested for primary PDO generation during the first biopsy/surgery. At the point of tumor recurrence, patients will be enrolled onto the main study to receive systemic therapy as second-line treatment. Subjects who undergo surgery at the time of recurrence will have a second harvest of tissue for PDO generation. Established PDOs will be subject to QPOP analyses to determine their therapeutic sensitivities to specific panels of drugs. A QPOP-guided treatment selection algorithm will then be used to select the most appropriate drug combination. The primary endpoint of the study is six-month progression-free survival. The secondary endpoints include twelve-month overall survival, RANO criteria and toxicities. In our radiological biomarker sub-study, we plan to evaluate novel radiopharmaceutical-based neuroimaging in determining blood-brain barrier permeability and to assess in vivo drug effects on tumor vasculature over time. TRIAL REGISTRATION: This trial was registered on 8th September 2022 with ClinicalTrials.gov Identifier: NCT05532397.


Sujet(s)
Tumeurs du cerveau , Récidive tumorale locale , Humains , Récidive tumorale locale/traitement médicamenteux , Récidive tumorale locale/anatomopathologie , Tumeurs du cerveau/traitement médicamenteux , Tumeurs du cerveau/anatomopathologie , Tumeurs du cerveau/imagerie diagnostique , Astrocytome/traitement médicamenteux , Astrocytome/anatomopathologie , Astrocytome/imagerie diagnostique , Organoïdes/effets des médicaments et des substances chimiques , Organoïdes/anatomopathologie , Organoïdes/imagerie diagnostique , Protocoles de polychimiothérapie antinéoplasique/usage thérapeutique , Grading des tumeurs
12.
BMC Med Imaging ; 24(1): 169, 2024 Jul 08.
Article de Anglais | MEDLINE | ID: mdl-38977957

RÉSUMÉ

BACKGROUND: Information complementarity can be achieved by fusing MR and CT images, and fusion images have abundant soft tissue and bone information, facilitating accurate auxiliary diagnosis and tumor target delineation. PURPOSE: The purpose of this study was to construct high-quality fusion images based on the MR and CT images of intracranial tumors by using the Residual-Residual Network (Res2Net) method. METHODS: This paper proposes an MR and CT image fusion method based on Res2Net. The method comprises three components: feature extractor, fusion layer, and reconstructor. The feature extractor utilizes the Res2Net framework to extract multiscale features from source images. The fusion layer incorporates a fusion strategy based on spatial mean attention, adaptively adjusting fusion weights for feature maps at each position to preserve fine details from the source images. Finally, fused features are input into the feature reconstructor to reconstruct a fused image. RESULTS: Qualitative results indicate that the proposed fusion method exhibits clear boundary contours and accurate localization of tumor regions. Quantitative results show that the method achieves average gradient, spatial frequency, entropy, and visual information fidelity for fusion metrics of 4.6771, 13.2055, 1.8663, and 0.5176, respectively. Comprehensive experimental results demonstrate that the proposed method preserves more texture details and structural information in fused images than advanced fusion algorithms, reducing spectral artifacts and information loss and performing better in terms of visual quality and objective metrics. CONCLUSION: The proposed method effectively combines MR and CT image information, allowing the precise localization of tumor region boundaries, assisting clinicians in clinical diagnosis.


Sujet(s)
Tumeurs du cerveau , Imagerie par résonance magnétique , Tomodensitométrie , Humains , Tomodensitométrie/méthodes , Tumeurs du cerveau/imagerie diagnostique , Imagerie par résonance magnétique/méthodes , Imagerie multimodale/méthodes , Algorithmes
13.
Acta Neurochir (Wien) ; 166(1): 292, 2024 Jul 10.
Article de Anglais | MEDLINE | ID: mdl-38985352

RÉSUMÉ

BACKGROUND: Intraoperative MRI (iMRI) has emerged as a useful tool in glioma surgery to safely improve the extent of resection. However, iMRI requires a dedicated operating room (OR) with an integrated MRI scanner solely for this purpose. Due to physical or economical restraints, this may not be feasible in all centers. The aim of this study was to investigate the feasibility of using a non-dedicated MRI scanner at the radiology department for iMRI and to describe the workflow with special focus on time expenditure and surgical implications. METHODS: In total, 24 patients undergoing glioma surgery were included. When the resection was deemed completed, the wound was temporarily closed, and the patient, under general anesthesia, was transferred to the radiology department for iMRI, which was performed using a dedicated protocol on 1.5 or 3 T scanners. After performing iMRI the patient was returned to the OR for additional tumor resection or final wound closure. All procedural times, timestamps, and adverse events were recorded. RESULT: The median time from the decision to initiate iMRI until reopening of the wound after scanning was 68 (52-104) minutes. Residual tumors were found on iMRI in 13 patients (54%). There were no adverse events during the surgeries, transfers, transportations, or iMRI-examinations. There were no wound-related complications or infections in the postoperative period or at follow-up. There were no readmissions within 30 or 90 days due to any complication. CONCLUSION: Performing intraoperative MRI using an MRI located outside the OR department was feasible and safe with no adverse events. It did not require more time than previously reported data for dedicated iMRI scanners. This could be a viable alternative in centers without access to a dedicated iMRI suite.


Sujet(s)
Tumeurs du cerveau , Gliome , Imagerie par résonance magnétique , Flux de travaux , Humains , Gliome/chirurgie , Gliome/imagerie diagnostique , Tumeurs du cerveau/chirurgie , Tumeurs du cerveau/imagerie diagnostique , Adulte d'âge moyen , Femelle , Mâle , Imagerie par résonance magnétique/méthodes , Adulte , Sujet âgé , Procédures de neurochirurgie/méthodes , Surveillance peropératoire/méthodes , Études de faisabilité , Blocs opératoires
14.
Neurosciences (Riyadh) ; 29(3): 201-206, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38981638

RÉSUMÉ

Benign fibrous histiocytoma (BFH) within the intracerebral region is remarkably rare. Our report details 2 cases of unusual BFH instances that exhibit no adhesion to the dura mater or cerebral falx, accompanied by a comprehensive literature review. While magnetic resonance imaging demonstrates specific characteristics for BFH, it does not readily differentiate BFH from more common brain neoplasms like gliomas and metastatic tumors. The definitive diagnosis of BFH depends primarily on histopathological and immunohistochemical examinations. Total surgical resection is considered an efficacious therapeutic approach, emphasizing the necessity for prolonged postoperative surveillance to detect any potential tumor recurrence or metastasis.


Sujet(s)
Tumeurs du cerveau , Histiocytome fibreux bénin , Imagerie par résonance magnétique , Humains , Tumeurs du cerveau/imagerie diagnostique , Tumeurs du cerveau/anatomopathologie , Histiocytome fibreux bénin/anatomopathologie , Histiocytome fibreux bénin/imagerie diagnostique , Histiocytome fibreux bénin/chirurgie
16.
Neurol India ; 72(3): 514-519, 2024 May 01.
Article de Anglais | MEDLINE | ID: mdl-39041966

RÉSUMÉ

BACKGROUND AND OBJECTIVES: Stereotactic biopsies are a relatively safe and reliable way of tissue diagnosis and characterization of eloquent area lesions/neoplasm. However, predicting the accuracy of the site of biopsy with the desired/planned site is not always possible. We describe a technique to identify the precise location of the biopsy site in the post-operative computed tomography (CT) scan using the injection of a low volume of air into the biopsy cannula. METHODS: Hundred consecutive biopsies were performed in 80 adults/20 children (59 males/41 females, median age 51 years) over 3 years, consisting of 75 frameless and 25 frame-based stereotactic biopsies. After the biopsy specimens had been collected, a small volume of air (median 1 cc) was injected into the site. Post-operative CT was done within 4 hours of the biopsy to see the site of the air bubble, and the same was correlated with the histopathological accuracy. RESULTS: Intra-cranial air in the selected target was present in 95 patients (Grade 1 and 2), while the air was seen in the track (Grade 3) in 3% and at an unrelated site (Grade 4) in 2% of cases. Both Grade 4 biopsies were negative on histopathology (diagnostic yield = 98%). Two negative biopsies were reported, which were both predicted with the Grade 4 biopsy. The grading allowed uniform reporting across series and eliminated the chance of upgrading/downgrading the report due to wrong site sampling within the lesion/neoplasm. CONCLUSION: The air-injection manoeuvre proposed for use in stereotactic biopsies of intra-cranial mass lesions is a safe and reliable technique that allows the exact biopsy site to be located without any related complications.


Sujet(s)
Air , Techniques stéréotaxiques , Tomodensitométrie , Humains , Femelle , Mâle , Adulte d'âge moyen , Biopsie/méthodes , Enfant , Adulte , Enfant d'âge préscolaire , Sujet âgé , Adolescent , Tumeurs du cerveau/anatomopathologie , Tumeurs du cerveau/imagerie diagnostique , Tumeurs du cerveau/diagnostic , Jeune adulte
17.
BMC Cancer ; 24(1): 866, 2024 Jul 18.
Article de Anglais | MEDLINE | ID: mdl-39026289

RÉSUMÉ

BACKGROUND: The identification of viable tumors and radiation necrosis after stereotactic radiosurgery (SRS) is crucial for patient management. Tumor habitat analysis involving the grouping of similar voxels can identify subregions that share common biology and enable the depiction of areas of tumor recurrence and treatment-induced change. This study aims to validate an imaging biomarker for tumor recurrence after SRS for brain metastasis by conducting tumor habitat analysis using multi-parametric MRI. METHODS: In this prospective study (NCT05868928), patients with brain metastases will undergo multi-parametric MRI before SRS, and then follow-up MRIs will be conducted every 3 months until 24 months after SRS. The multi-parametric MRI protocol will include T2-weighted and contrast-enhanced T1-weighted imaging, diffusion-weighted imaging, and dynamic susceptibility contrast imaging. Using k-means voxel-wise clustering, this study will define three structural MRI habitats (enhancing, solid low-enhancing, and nonviable) on T1- and T2-weighted images and three physiologic MRI habitats (hypervascular cellular, hypovascular cellular, and nonviable) on apparent diffusion coefficient maps and cerebral blood volume maps. Using RANO-BM criteria as the reference standard, via Cox proportional hazards analysis, the study will prospectively evaluate associations between parameters of the tumor habitats and the time to recurrence. The DICE similarity coefficients between the recurrence site and tumor habitats will be calculated. DISCUSSION: The tumor habitat analysis will provide an objective and reliable measure for assessing tumor recurrence from brain metastasis following SRS. By identifying subregions for local recurrence, our study could guide the next therapeutic targets for patients after SRS. TRIAL REGISTRATION: This study is registered at ClinicalTrials.gov (NCT05868928).


Sujet(s)
Tumeurs du cerveau , Récidive tumorale locale , Radiochirurgie , Humains , Radiochirurgie/méthodes , Tumeurs du cerveau/secondaire , Tumeurs du cerveau/imagerie diagnostique , Tumeurs du cerveau/chirurgie , Tumeurs du cerveau/radiothérapie , Récidive tumorale locale/imagerie diagnostique , Récidive tumorale locale/anatomopathologie , Études prospectives , Femelle , Mâle , Imagerie par résonance magnétique/méthodes , Adulte d'âge moyen , Adulte , Sujet âgé , Appréciation des risques/méthodes
18.
BMC Med Imaging ; 24(1): 177, 2024 Jul 19.
Article de Anglais | MEDLINE | ID: mdl-39030508

RÉSUMÉ

BACKGROUND: Cancer pathology shows disease development and associated molecular features. It provides extensive phenotypic information that is cancer-predictive and has potential implications for planning treatment. Based on the exceptional performance of computational approaches in the field of digital pathogenic, the use of rich phenotypic information in digital pathology images has enabled us to identify low-level gliomas (LGG) from high-grade gliomas (HGG). Because the differences between the textures are so slight, utilizing just one feature or a small number of features produces poor categorization results. METHODS: In this work, multiple feature extraction methods that can extract distinct features from the texture of histopathology image data are used to compare the classification outcomes. The successful feature extraction algorithms GLCM, LBP, multi-LBGLCM, GLRLM, color moment features, and RSHD have been chosen in this paper. LBP and GLCM algorithms are combined to create LBGLCM. The LBGLCM feature extraction approach is extended in this study to multiple scales using an image pyramid, which is defined by sampling the image both in space and scale. The preprocessing stage is first used to enhance the contrast of the images and remove noise and illumination effects. The feature extraction stage is then carried out to extract several important features (texture and color) from histopathology images. Third, the feature fusion and reduction step is put into practice to decrease the number of features that are processed, reducing the computation time of the suggested system. The classification stage is created at the end to categorize various brain cancer grades. We performed our analysis on the 821 whole-slide pathology images from glioma patients in the Cancer Genome Atlas (TCGA) dataset. Two types of brain cancer are included in the dataset: GBM and LGG (grades II and III). 506 GBM images and 315 LGG images are included in our analysis, guaranteeing representation of various tumor grades and histopathological features. RESULTS: The fusion of textural and color characteristics was validated in the glioma patients using the 10-fold cross-validation technique with an accuracy equals to 95.8%, sensitivity equals to 96.4%, DSC equals to 96.7%, and specificity equals to 97.1%. The combination of the color and texture characteristics produced significantly better accuracy, which supported their synergistic significance in the predictive model. The result indicates that the textural characteristics can be an objective, accurate, and comprehensive glioma prediction when paired with conventional imagery. CONCLUSION: The results outperform current approaches for identifying LGG from HGG and provide competitive performance in classifying four categories of glioma in the literature. The proposed model can help stratify patients in clinical studies, choose patients for targeted therapy, and customize specific treatment schedules.


Sujet(s)
Algorithmes , Tumeurs du cerveau , Couleur , Gliome , Grading des tumeurs , Humains , Tumeurs du cerveau/imagerie diagnostique , Tumeurs du cerveau/anatomopathologie , Tumeurs du cerveau/classification , Gliome/imagerie diagnostique , Gliome/anatomopathologie , Gliome/classification , Diagnostic assisté par ordinateur/méthodes , Interprétation d'images assistée par ordinateur/méthodes
19.
Pharmacol Res ; 206: 107308, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-39019336

RÉSUMÉ

Glioma is the most common intracranial malignant tumor, with severe difficulty in treatment and a low patient survival rate. Due to the heterogeneity and invasiveness of tumors, lack of personalized clinical treatment design, and physiological barriers, it is often difficult to accurately distinguish gliomas, which dramatically affects the subsequent diagnosis, imaging treatment, and prognosis. Fortunately, nano-delivery systems have demonstrated unprecedented capabilities in diagnosing and treating gliomas in recent years. They have been modified and surface modified to efficiently traverse BBB/BBTB, target lesion sites, and intelligently release therapeutic or contrast agents, thereby achieving precise imaging and treatment. In this review, we focus on nano-delivery systems. Firstly, we provide an overview of the standard and emerging diagnostic and treatment technologies for glioma in clinical practice. After induction and analysis, we focus on summarizing the delivery methods of drug delivery systems, the design of nanoparticles, and their new advances in glioma imaging and treatment in recent years. Finally, we discussed the prospects and potential challenges of drug-delivery systems in diagnosing and treating glioma.


Sujet(s)
Tumeurs du cerveau , Systèmes de délivrance de médicaments , Gliome , Humains , Gliome/traitement médicamenteux , Gliome/imagerie diagnostique , Gliome/diagnostic , Tumeurs du cerveau/traitement médicamenteux , Tumeurs du cerveau/imagerie diagnostique , Tumeurs du cerveau/diagnostic , Animaux , Antinéoplasiques/administration et posologie , Antinéoplasiques/usage thérapeutique , Nanoparticules , Barrière hémato-encéphalique/métabolisme , Barrière hémato-encéphalique/effets des médicaments et des substances chimiques , Système d'administration de médicaments à base de nanoparticules
20.
Cancer Imaging ; 24(1): 95, 2024 Jul 18.
Article de Anglais | MEDLINE | ID: mdl-39026377

RÉSUMÉ

BACKGROUND: Radiotherapy is a major therapeutic approach in patients with brain tumors. However, it leads to cognitive impairments. To improve the management of radiation-induced brain sequalae, deformation-based morphometry (DBM) could be relevant. Here, we analyzed the significance of DBM using Jacobian determinants (JD) obtained by non-linear registration of MRI images to detect local vulnerability of healthy cerebral tissue in an animal model of brain irradiation. METHODS: Rats were exposed to fractionated whole-brain irradiation (WBI, 30 Gy). A multiparametric MRI (anatomical, diffusion and vascular) study was conducted longitudinally from 1 month up to 6 months after WBI. From the registration of MRI images, macroscopic changes were analyzed by DBM and microscopic changes at the cellular and vascular levels were evaluated by quantification of cerebral blood volume (CBV) and diffusion metrics including mean diffusivity (MD). Voxel-wise comparisons were performed on the entire brain and in specific brain areas identified by DBM. Immunohistology analyses were undertaken to visualize the vessels and astrocytes. RESULTS: DBM analysis evidenced time-course of local macrostructural changes; some of which were transient and some were long lasting after WBI. DBM revealed two vulnerable brain areas, namely the corpus callosum and the cortex. DBM changes were spatially associated to microstructural alterations as revealed by both diffusion metrics and CBV changes, and confirmed by immunohistology analyses. Finally, matrix correlations demonstrated correlations between JD/MD in the early phase after WBI and JD/CBV in the late phase both in the corpus callosum and the cortex. CONCLUSIONS: Brain irradiation induces local macrostructural changes detected by DBM which could be relevant to identify brain structures prone to radiation-induced tissue changes. The translation of these data in patients could represent an added value in imaging studies on brain radiotoxicity.


Sujet(s)
Lésions encéphaliques , Animaux , Rats , Mâle , Lésions encéphaliques/étiologie , Lésions encéphaliques/imagerie diagnostique , Lésions encéphaliques/anatomopathologie , Tumeurs du cerveau/radiothérapie , Tumeurs du cerveau/imagerie diagnostique , Tumeurs du cerveau/anatomopathologie , Lésions radiques/imagerie diagnostique , Lésions radiques/anatomopathologie , Lésions radiques/étiologie , Encéphale/effets des radiations , Encéphale/imagerie diagnostique , Encéphale/anatomopathologie , Imagerie par résonance magnétique/méthodes , Lésions radiques expérimentales/imagerie diagnostique , Lésions radiques expérimentales/anatomopathologie , Lésions radiques expérimentales/étiologie , Imagerie par résonance magnétique multiparamétrique/méthodes
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE